Application status of SWARA method in clinical comprehensive evaluation of drugs
- VernacularTitle:SWARA方法在药品临床综合评价中的应用现状
- Author:
Yalin WEN
1
;
Xia SHI
2
;
Enwu LONG
3
;
Rongsheng TONG
3
;
Xingwei WU
1
Author Information
1. Dept. of Pharmacy，Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital，Chengdu 610072，China
2. Personalized Drug Therapy Key Laboratory of Sichuan Province，School of Medicine，University of Electronic Science and Technology of China，Chengdu 610072，China
3. Dept. of Pharmacy，Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital，Chengdu 610072，China;Personalized Drug Therapy Key Laboratory of Sichuan Province，School of Medicine，University of Electronic Science and Technology of China，Chengdu 610072，China
- Publication Type:Journal Article
- Keywords:
step-wise weight assessment ratio analysis;
clinical comprehensive evaluation of drugs;
multi-criteria decision
- From:
China Pharmacy
2022;33(19):2428-2432
- CountryChina
- Language:Chinese
-
Abstract:
Clinical comprehensive evaluation of drugs is an important technical tool for drug supply assurance decision - making，which requires evaluation subjects to use multiple evaluation methods and tools to carry out a comprehensive evaluation of multi-dimensional and multi -level evidence for drugs . Multi-criteria decision analysis （MCDA）is an important method for clinical comprehensive evaluation of drugs ，including weight assignment and comprehensive evaluation . Step-wise weight assessment ratio analysis（SWARA）is a weighting method for MCDA ，which can determine indicator weight concisely and accurately compared to other methods . This paper introduces the method of SWARA ，and systematically reviews the application of SWARA in the comprehensive clinical evaluation of drugs . Currently，the SWARA method is used in various research areas . Within the field of pharmaceuticals，researchers use the SWARA method to build MCDA models and calculate specific weight values for each drug evaluation criterion by consulting a team of experts . The advantage of SWARA is that it provides a brand -new way of assigning the weight of drug evaluation criterion by consulting experts ’opinions or judgments according to corresponding steps to solve the MCDA problem in the medical field ；however，it has certain subjectivity and uncertainty in solving complex decision -making problems，and there may also be problems such as insufficient screening of evaluation criterion and incomplete coverage of topics ， which should be paid attention to in application .
